Personal information

Other IDs

ResearcherID: AAE-3247-2019

Countries

Denmark

Activities

Collapse all

Employment (1)

Rigshospitalet: Copenhagen, DK

MD (Department of Hematology)
Employment
Source: Self-asserted source
Lars Klingen Gjærde

Education and qualifications (2)

University of Copenhagen: Copenhagen, DK

2022 | PhD
Education
Source: Self-asserted source
Lars Klingen Gjærde

University of Copenhagen: Copenhagen, DK

2016 | MD
Education
Source: Self-asserted source
Lars Klingen Gjærde

Works (20)

Fitting parametric cure models in R using the packages cuRe and rstpm2

Computer Methods and Programs in Biomedicine
2022-11 | Journal article
DOI: 10.1016/j.cmpb.2022.107125
Contributors: Lars Klingen Gjærde
Source: Self-asserted source
Lars Klingen Gjærde

Hypomethylating agent-based therapies in older adults with acute myeloid leukemia – A joint review by the Young International Society of Geriatric Oncology and European Society for Blood and Marrow Transplantation Trainee Committee

Journal of Geriatric Oncology
2022-11 | Journal article
DOI: 10.1016/j.jgo.2022.11.005
Contributors: Lars Klingen Gjærde; Nina Rosa Neuendorff; Nico Gagelmann; Surbhi Singhal; Shelby Meckstroth; Vincent Thibaud; Yue Zhao; Nabiel Mir; Yung-Yu Shih; Danielle M.C. Amaro et al.
Source: Self-asserted source
Lars Klingen Gjærde

Pre-Transplantation Plasma ST2 Level as a Prognostic Biomarker of 1-Year Non-Relapse Mortality in Allogeneic Hematopoietic Cell Transplantation

Transplantation and Cellular Therapy
2022-11 | Journal article | Author
DOI: 10.1016/j.jtct.2022.11.009
Contributors: Lars Klingen Gjærde; Sisse Rye Ostrowski; Frederikke Schierbeck; Niels Smedegaard Andersen; Lone Smidstrup Friis; Brian Kornblit; Søren Lykke Petersen; Ida Schjødt; Henrik Sengeløv
Source: Self-asserted source
Lars Klingen Gjærde

Sexual function of adult long-term survivors and their partners after allogeneic hematopoietic cell transplantation in Europe (S-FAST): a study from the Transplant Complications Working Party and Nurses Group of the EBMT

Bone Marrow Transplantation
2022-11-14 | Journal article | Author
DOI: 10.1038/s41409-022-01869-2
Contributors: Lars Klingen Gjærde; Corien Eeltink; Jacqui Stringer; Jarl Mooyaart; Paul Bosman; Michelle Kenyon; sarah liptrott; Diana Greenfield; Andrea Linke; Pascal Turlure et al.
Source: Self-asserted source
Lars Klingen Gjærde

Trends in survival and cure after allogeneic haematopoietic cell transplantation for acute myeloid leukaemia from 2000 to 2020: A Danish population‐based cohort study

British Journal of Haematology
2022-10-20 | Journal article | Author
DOI: 10.1111/bjh.18511
Contributors: Lars Klingen Gjærde; Lasse H. Jakobsen; Caroline Juhl‐Christensen; Gitte Olesen; Irma Petruskevicius; Marianne Tang Severinsen; Claus W. Marcher; Kim Theilgaard‐Mönch; Niels S. Andersen; Lone S. Friis et al.
Source: Self-asserted source
Lars Klingen Gjærde

Early stimulated immune responses predict clinical disease severity in hospitalized COVID-19 patients

Communications Medicine
2022-09-12 | Journal article
DOI: 10.1038/s43856-022-00178-5
PMID: 36101705
Contributors: Lars Klingen Gjærde
Source: Self-asserted source
Lars Klingen Gjærde

Ocular Chronic Graft-Versus-Host Disease and Its Relation to Other Organ Manifestations and Outcomes After Allogeneic Haematopoietic Cell Transplantation

Transplantation and Cellular Therapy
2022-08 | Journal article
DOI: 10.1016/j.jtct.2022.08.016
PMID: 36002105
Contributors: Lars Klingen Gjærde
Source: Self-asserted source
Lars Klingen Gjærde

Pre-transplantation vitamin E levels and acute graft-versus-host disease after non-myeloablative allogeneic hematopoietic cell transplantation

Transplant Immunology
2022-06 | Journal article
DOI: 10.1016/j.trim.2022.101650
PMID: 35718288
Source: Self-asserted source
Lars Klingen Gjærde

Recognising inequalities in haematopoietic stem-cell transplantation and cellular therapy training

The Lancet Haematology
2022-03 | Journal article
DOI: 10.1016/s2352-3026(22)00081-3
PMID: 35313128
Source: Self-asserted source
Lars Klingen Gjærde

Cytokine autoantibodies are stable throughout the haematopoietic stem cell transplantation course and are associated with distinct biomarker and blood cell profiles

Scientific Reports
2021-12 | Journal article
DOI: 10.1038/s41598-021-01952-6
PMID: 34907183
Source: Self-asserted source
Lars Klingen Gjærde

Pre-transplantation plasma vitamin D levels and acute graft-versus-host disease after myeloablative hematopoietic cell transplantation in adults

Transplant Immunology
2021-10 | Journal article
DOI: 10.1016/j.trim.2021.101437
PMID: 34273495
Source: Self-asserted source
Lars Klingen Gjærde

Improved survival after allogeneic transplantation for acute lymphoblastic leukemia in adults: a Danish population-based study

Leukemia & Lymphoma
2021-10-21 | Journal article
DOI: 10.1080/10428194.2021.1992620
PMID: 34672245
Source: Self-asserted source
Lars Klingen Gjærde

Platelet and Red Blood Cell Transfusions and Risk of Acute Graft-versus-Host Disease after Myeloablative Allogeneic Hematopoietic Cell Transplantation

Transplantation and Cellular Therapy
2021-07 | Journal article
DOI: 10.1016/j.jtct.2021.07.001
PMID: 34252580
Source: Self-asserted source
Lars Klingen Gjærde

Functional immune reconstitution early after allogeneic hematopoietic cell transplantation: A comparison of pre- and post-transplantation cytokine responses in stimulated whole-blood.

Scandinavian journal of immunology
2021-03-26 | Journal article
DOI: 10.1111/sji.13042
PMID: 33772836
Source: Self-asserted source
Lars Klingen Gjærde

Vitamin E and acute graft‐versus‐host disease after myeloablative allogeneic hematopoietic cell transplantation

European Journal of Haematology
2020-12-12 | Journal article
DOI: 10.1111/ejh.13567
PMID: 33314420
Source: Self-asserted source
Lars Klingen Gjærde

Pretransplantation vitamin A plasma levels and risk of acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation

Bone Marrow Transplantation
2019-11-26 | Journal article
DOI: 10.1038/s41409-019-0760-5
PMID: 31772337
Source: Self-asserted source
Lars Klingen Gjærde

Incidence of hepatocellular carcinoma in HIV/HBV-coinfected patients on tenofovir therapy: Relevance for screening strategies.

Journal of hepatology
2019-04-06 | Journal article
DOI: 10.1016/j.jhep.2019.03.032
PMID: 30965070
Source: Self-asserted source
Lars Klingen Gjærde

Gut decontamination during allogeneic hematopoietic stem cell transplantation and the risk of acute graft-versus-host disease.

Bone marrow transplantation
2018-02-28 | Journal article
DOI: 10.1038/s41409-018-0131-7
PMID: 29491465
Source: Self-asserted source
Lars Klingen Gjærde

Epidemiology of bloodstream infections after myeloablative and non-myeloablative allogeneic hematopoietic stem cell transplantation: A single-center cohort study.

Transplant infectious disease : an official journal of the Transplantation Society
2017-10 | Journal article
DOI: 10.1111/tid.12730
PMID: 28561378
Source: Self-asserted source
Lars Klingen Gjærde via Europe PubMed Central

Trends in Incidences and Risk Factors for Hepatocellular Carcinoma and Other Liver Events in HIV and Hepatitis C Virus-coinfected Individuals From 2001 to 2014: A Multicohort Study.

Clinical Infectious Diseases
2016-09 | Journal article
DOI: 10.1093/cid/ciw380
PMID: 27307505
Source: Self-asserted source
Lars Klingen Gjærde
How many people are using ORCID?